In a study on the colon cancer, researchers found that KRAS mutations can activate the transcription factor TFCP2, which in turn upregulates the expression of adipogenic factors BMP4 and WNT5B, ultimately inducing CAFs to transform into a special subtype rich in lipids. This evidence concerns the gene KRAS and colonic neoplasm.